Eurofins lands $30M COVID diagnostic testing contract
October 18, 2021 -- Eurofins Genomics has won a $30 million contract with the U.S. Department of Air Force and the U.S. Department of Health and Human Services to build a new production facility for manufacturing reagents used in COVID-19 diagnostic tests. Read More
Stilla launches Naica 6-color digital PCR system
October 18, 2021 -- Stilla Technologies has launched Naica, a digital polymerase chain reaction (PCR) system that features six fluorescent channels. Naica was introduced at the American Society of Human Genetics virtual meeting. Read More
Quest Diagnostics debuts new lab facility in NJ
October 14, 2021 -- Quest Diagnostics has finished integrating its Northeast regional operations into a new 25,000-sq-ft, next-generation lab facility in Clifton, NJ. Read More
Prenosis, Roche expand partnership to combat sepsis
October 14, 2021 -- Prenosis and Roche Diagnostics will expand their existing partnership with a $6 million infusion to improve and expedite the clinical identification of sepsis through advanced precision diagnostics. Read More
Half of world lacks access to diagnostic testing
October 12, 2021 -- Nearly half (47%) of the world's population has little to no access to diagnostic testing, including the ability to do cultures to identify microorganisms or access to a chemical analyzer or to a hematology analyzer, according to a report released on October 6 in Lancet. Read More
How AI for cervical cancer can help achieve healthcare equity
October 11, 2021 -- Despite cervical cancer being among the most treatable forms of cancer, it continues to kill hundreds of thousands of women globally each year, especially in low-income areas. Artificial intelligence (AI) could help, according to Michael Quick of Hologic. Read More
Quidel expects financial gains for Q3
October 8, 2021 -- In preliminary results, Quidel reported that it expects to report growth in revenue in the third quarter of its 2021 fiscal year, which the company said is partially due to increased shipments of tests for SARS-CoV-2. Read More
Study casts doubt on D-dimer test to exclude PE in COVID patients
October 8, 2021 -- A retrospective diagnostic study evaluating the practice of using D-dimer assays to exclude pulmonary embolism (PE) among hospitalized COVID-19 patients showed that the test had limited clinical utility. The findings were published on October 8 in JAMA Network Open. Read More
PerkinElmer receives EUA for respiratory SARS-CoV-2 panel
October 7, 2021 -- PerkinElmer has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its PKamp Respiratory SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) Panel 1. Read More
Lumos touts cost savings for point-of-care infection test
October 7, 2021 -- Lumos Diagnostics is highlighting clinical results that suggest its FebriDx point-of-care test to guide antibiotic treatment in patients with respiratory infections could save $2.5 billion annually in healthcare costs. Read More
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current